Central nervous system metastasis from epithelial ovarian cancer- predictors of outcome

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 71, 209, 10.3322/caac.21660 Berek, 2021, Cancer of the ovary, fallopian tube, and peritoneum: 2021 update, Int J Gynecol Obstet, 155, 61, 10.1002/ijgo.13878 O'Malley, 2019, New therapies for ovarian cancer, J Natl Compr Canc Netw, 17, 619 Odunsi, 2017, Immunotherapy in ovarian cancer, Ann Oncol, 28, viii 1, 10.1093/annonc/mdx444 Kumar, 2015, Neoadjuvant chemotherapy in gynaecological cancers – Implications for staging, Best Pract Res Clin Obstet Gynaecol, 29, 790, 10.1016/j.bpobgyn.2015.02.008 Borella, 2020, Brain metastases from ovarian cancer: current evidence in diagnosis, treatment, and prognosis, Cancers, 12, 2156, 10.3390/cancers12082156 Tabouret, 2012, Recent trends in epidemiology of brain metastases: an overview, Anticancer Res, 32, 4655 Deshpande K, Buchanan I, Martirosian V, Neman J. Clinical perspectives in brain metastasis. cold spring harb perspect med. 2020;10:a037051. Larson, 1986, Central nervous system metastases in epithelial ovarian carcinoma, Obstet Gynecol, 68, 746 Rodriguez, 1992, Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery, J Clin Oncol, 10, 1553, 10.1200/JCO.1992.10.10.1553 Mittica, 2020, Validation of androgen receptor loss as a risk factor for the development of brain metastases from ovarian cancers, J Ovarian Res, 13, 53, 10.1186/s13048-020-00655-2 lin, 2014, Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer, BMC Cancer, 14, 829, 10.1186/1471-2407-14-829 Gill, 2021, Tumor immune microenvironment in brain metastases from gynecologic malignancies, Cancer Immunol Immunother, 70, 2951, 10.1007/s00262-021-02909-4 Choi, 2019, Integrative immunologic and genomic characterization of brain metastasis from ovarian/peritoneal cancer, Pathol Res Pract, 215, 10.1016/j.prp.2019.03.032 Ratner, 2019, Increased risk of brain metastases in ovarian cancer patients with BRCA mutations, Gynecol Oncol, 153, 568, 10.1016/j.ygyno.2019.03.004 Jernigan, 2015, Epithelial ovarian cancer metastatic to the central nervous system and a family history concerning for hereditary breast and ovarian cancer–a potential relationship, Int J Gynecol Cancer, 25, 1232, 10.1097/IGC.0000000000000489 Stasenko, 2019, Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation status, Gynecol Oncol, 154, 144, 10.1016/j.ygyno.2019.05.004 Lee, 2008, Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer, Gynecol Oncol, 108, 505, 10.1016/j.ygyno.2007.11.027 Ogino, 2012, Gamma knife surgery for brain metastases from ovarian cancer, Acta Neurochir (Wien), 154, 1669, 10.1007/s00701-012-1376-3 Niu, 2013, Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival, J Obstet Gynaecol Can, 35, 816, 10.1016/S1701-2163(15)30838-0 Lai, 2021, Gamma knife radiosurgery-based combination treatment strategies improve survival in patients with central nervous system metastases from epithelial ovarian cancer: a retrospective analysis of two academic institutions in Korea and Taiwan, Front Oncol, 11, 10.3389/fonc.2021.719936 Pectasides, 2006, Brain metastases from epithelial ovarian cancer: a review of the literature, The Oncologist, 11, 252, 10.1634/theoncologist.11-3-252 Tate, 2022, Bevacizumab-based salvage chemotherapy improves survival outcomes for patients with brain metastasis from ovarian cancer, Anticancer Res, 42, 2637, 10.21873/anticanres.15741 Kasherman, 2021, Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases, Int J Gynecol Cancer, 31, 139, 10.1136/ijgc-2020-001849 Sakamoto, 2019, Durable response by olaparib for a Japanese patient with primary peritoneal cancer with multiple brain metastases: a case report: durable response by olaparib, J Obstet Gynaecol Res, 45, 743, 10.1111/jog.13851 Zhang, 2022, Successful treatment of a patient with brain metastasis from ovarian cancer with brca wild type using niraparib: a case report and review of the literature, Front Oncol, 12 Chiang, 2012, Brain metastases from epithelial ovarian carcinoma: evaluation of prognosis and managements - a Taiwanese Gynecologic Oncology Group (TGOG) study, Gynecol Oncol, 125, 37, 10.1016/j.ygyno.2011.12.438 Marchetti, 2016, Brain metastases in patients with EOC: clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19), Gynecol Oncol, 143, 532, 10.1016/j.ygyno.2016.09.025 Sehouli, 2010, Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study, Ann Oncol, 21, 2201, 10.1093/annonc/mdq229 Teckie, 2013, Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival, Radiat Oncol, 8, 36, 10.1186/1748-717X-8-36 Kwon, 2018, Treatment results and prognostic factors of brain metastases from ovarian cancer: a single institutional experience of 56 patients, Int J Gynecol Cancer, 28, 1631, 10.1097/IGC.0000000000001341 da Costa, 2019, Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis, BMC Cancer, 19, 1194, 10.1186/s12885-019-6382-x Celejewska, 2014, Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients, J Ovarian Res, 7, 79, 10.1186/s13048-014-0079-1 Seber, 2017, Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology, Eur J Gynaecol Oncol, 38, 227 Wohl, 2019, Brain metastases from ovarian carcinoma: An evaluation of prognostic factors and treatment, Neurol India, 67, 1431, 10.4103/0028-3886.273627 Anupol, 2002, Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases, Gynecol Oncol, 85, 487, 10.1006/gyno.2002.6653 Matsunaga, 2016, Gamma knife surgery for metastatic brain tumors from gynecologic cancer, World Neurosurg, 89, 455, 10.1016/j.wneu.2016.01.062 Leroux, 1991, Cerebral metastases from ovarian carcinoma, Cancer, 67, 2194, 10.1002/1097-0142(19910415)67:8<2194::AID-CNCR2820670832>3.0.CO;2-# Kumar, 2003, Central nervous system metastases from primary epithelial ovarian cancer, Cancer Control, 10, 244, 10.1177/107327480301000309